Topic · page 38 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,481–1,520 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lupus31 Aug 2023
Impact of online health information-seeking behavior on shared decision-making in patients with systemic lupus erythematosus: The TRUMP 2 -SLE project
Cross-sectional study
Scand J Rheumatol31 Aug 2023
Belimumab therapy for refractory immune thrombocytopenia in systemic lupus erythematosus patients with anti-phospholipid antibodies
Cohort study
Ann Rheum Dis28 Aug 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Diagnostic or prognostic study
Arthritis Rheumatol28 Aug 2023
The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria
Diagnostic or prognostic study
Lupus28 Aug 2023
Clustering of systemic lupus erythematosus mortality in southwestern Spain
Research article
Lupus26 Aug 2023
Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus
Cross-sectional study
Rheumatology (Oxford)26 Aug 2023
Mortality and causes of death in systemic lupus erythematosus in New Zealand: a population-based study
Cohort study
Lupus23 Aug 2023
Expression patterns of T cells-specific long noncoding RNAs in systemic lupus erythematosus patients carrying HLA risk/nonrisk alleles
Cross-sectional study
Arthritis Res Ther23 Aug 2023
Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model
Cohort study
Lupus Sci Med22 Aug 2023
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial
Secondary analysis
Lupus Sci Med22 Aug 2023
Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
Cohort study
Scand J Rheumatol22 Aug 2023
Total iron binding capacity: an independent predictor of prognosis for pulmonary arterial hypertension in systemic lupus erythematosus
Cohort study
RMD Open21 Aug 2023
Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysis
Randomized controlled trial
Lupus Sci Med21 Aug 2023
State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus
Cohort study
Lupus19 Aug 2023
Telomere length and its association with systemic lupus erythematosus in an Asian population: A Mendelian randomization study
Research article
Rheumatology (Oxford)17 Aug 2023
Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus
Cohort study
RMD Open17 Aug 2023
Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020–2021
Cohort study
Arthritis Rheumatol17 Aug 2023
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti‐CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Trial
Randomized controlled trial
Lupus17 Aug 2023
Prevalence of cognitive impairment and cognitive improvement in patients with systemic lupus erythematosus during a 6-month follow-up study
Cohort study
Scand J Rheumatol16 Aug 2023
Anti-thrombotics and major adverse cardiovascular events in anti-phospholipid syndrome: a cross-sectional study using the 2016–2018 National Inpatient Sample database
Cross-sectional study
Lupus Sci Med16 Aug 2023
Abnormally high expression of D1-like dopamine receptors on lupus CD4+ T cells promotes Tfh cell differentiation
Mechanistic study
Arthritis Res Ther14 Aug 2023
Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
Research article
Clin Exp Rheumatol13 Aug 2023
The meaning of non-criteria clinical manifestations in a real-life primary antiphospholipid syndrome cohort
Cohort study
Rheumatology (Oxford)12 Aug 2023
Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus
Cross-sectional study
Rheumatology (Oxford)12 Aug 2023
Heart valve disease in primary antiphospholipid syndrome
Cohort study
Ann Rheum Dis11 Aug 2023
Interleukin 4-driven reversal of self-reactive B cell anergy contributes to the pathogenesis of systemic lupus erythematosus
Mechanistic study
Semin Arthritis Rheum10 Aug 2023
Long-term outcome of status epilepticus-related to systemic lupus erythematosus: An observational study and a systematic review
Meta-analysis
Rheumatology (Oxford)9 Aug 2023
Comparison of two frailty definitions in women with systemic lupus erythematosus
Cross-sectional study
Lupus Sci Med9 Aug 2023
Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density
Cross-sectional study
RMD Open9 Aug 2023
Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome
Cross-sectional study
RMD Open2 Aug 2023
Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
Research article
Clin Exp Rheumatol1 Aug 2023
Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients
Cohort study
Lupus Sci Med31 Jul 2023
Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries
Cohort study
Lupus30 Jul 2023
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis
Meta-analysis
RMD Open28 Jul 2023
Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort
Cohort study
Lupus27 Jul 2023
Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents
Guideline or statement
Rheumatology (Oxford)27 Jul 2023
Incidence of and risk factors for myelodysplastic syndrome in patients with rheumatologic diseases
Cohort study
Lupus Sci Med27 Jul 2023
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
Research article
Lupus24 Jul 2023
Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient data
Meta-analysis
Lupus24 Jul 2023
Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 1,481–1,520 of 1,848, newest first